Citadel Advisors’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,493
Closed -$651K 13924
2025
Q4
$651K Buy
+22,493
New +$427K ﹤0.01% 8379
2025
Q3
Hold
0
13773
2025
Q2
Hold
0
14257
2025
Q1
Sell
-16,854
Closed -$260K 15297
2024
Q4
$603K Sell
16,854
-159,608
-90% -$8.26M ﹤0.01% 8153
2024
Q3
$8.34M Buy
176,462
+66,718
+61% +$2.94M 0.01% 3189
2024
Q2
$5.51M Sell
109,744
-28,615
-21% -$2.07M 0.01% 3598
2024
Q1
$15.5M Buy
138,359
+61,282
+80% +$6.09M 0.01% 2359
2023
Q4
$4.47M Buy
77,077
+12,488
+19% +$502K ﹤0.01% 3959
2023
Q3
$2.05M Buy
64,589
+64,586
+2,152,867% +$3.07M ﹤0.01% 5151
2023
Q2
$250 Sell
3
-4,503
-100% -$659K ﹤0.01% 14169
2023
Q1
$463K Sell
4,506
-20,517
-82% -$2.88M ﹤0.01% 8476
2022
Q4
$3.67M Buy
25,023
+17,947
+254% +$3.03M ﹤0.01% 4406
2022
Q3
$1.2M Sell
7,076
-6,981
-50% -$1.13M ﹤0.01% 6602
2022
Q2
$1.62M Sell
14,057
-13,411
-49% -$1.26M ﹤0.01% 5985
2022
Q1
$2.74M Buy
27,468
+15,128
+123% +$1.77M ﹤0.01% 5395
2021
Q4
$1.92M Buy
12,340
+10,466
+558% +$2.04M ﹤0.01% 6343
2021
Q3
$442K Sell
1,874
-21,691
-92% -$6.34M ﹤0.01% 10182
2021
Q2
$8M Buy
23,565
+2,029
+9% +$768K 0.01% 3483
2021
Q1
$8.71M Sell
21,536
-56,665
-72% -$27.5M 0.01% 3191
2020
Q4
$52M Buy
78,201
+61,473
+367% +$34.2M 0.06% 923
2020
Q3
$7.79M Sell
16,728
-7,200
-30% -$3.64M 0.01% 2597
2020
Q2
$14M Buy
23,928
+5,481
+30% +$1.87M 0.02% 1846
2020
Q1
$2.69M Buy
18,447
+9,643
+110% +$1.69M ﹤0.01% 3649
2019
Q4
$1.26M Buy
8,804
+5,077
+136% +$371K ﹤0.01% 5183
2019
Q3
$147K Buy
3,727
+502
+16% +$36.5K ﹤0.01% 8312
2019
Q2
$326K Buy
3,225
+1,363
+73% +$161K ﹤0.01% 7451
2019
Q1
$245K Sell
1,862
-100
-5% -$12.6K ﹤0.01% 7908
2018
Q4
$200K Buy
+1,962
New +$310K ﹤0.01% 7860
2017
Q3
Sell
-513
Closed -$179K 7909
2017
Q2
$179K Buy
+513
New +$177K ﹤0.01% 6633

Other funds holding MRSN